Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05221320 |
Title | Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) Malignancies |
Recruitment | Terminated |
Gender | both |
Phase | Phase II |
Variant Requirements | Yes |
Sponsors | BioMed Valley Discoveries, Inc |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Arizona Cancer Center | Tucson | Arizona | 85719 | United States | Details | |
University of California San Francisco | San Francisco | California | 94143 | United States | Details | |
University of Kansas Cancer Center | Fairway | Kansas | 66205 | United States | Details | |
Rogel Cancer Center, University of Michigan Health | Ann Arbor | Michigan | 48109 | United States | Details | |
Washington University School of Medicine | Saint Louis | Missouri | 63110 | United States | Details | |
Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | 08903 | United States | Details | |
Mount Sinai | New York | New York | 10029 | United States | Details | |
Cleveland Clinic | Cleveland | Ohio | 44195 | United States | Details | |
Massey Cancer Center, Virginia Commonwealth University | Richmond | Virginia | 23298 | United States | Details |